Structural modification induced in heparin by a Fenton-type depolymerization process
- PMID: 17629843
- DOI: 10.1055/s-2007-982077
Structural modification induced in heparin by a Fenton-type depolymerization process
Abstract
A low molecular weight heparin (LMWH) obtained by a depolymerization process induced by a Fenton-type reagent was characterized in depth by nuclear magnetic resonance (NMR) spectroscopy. The depolymerization involves the cleavage of glycosidic bonds, leading to natural terminal reducing end residues, mainly represented by N-sulfated glucosamine (A (NS)). Natural uronic acids, especially the 2- O-sulfate iduronic acid (I (2S)), are also present as reducing residues. A peculiar reaction results, such as the disappearance of the nonsulfated iduronic acid residues when followed by 6-O-nonsulfated glucosamine, and the decrease of the glucuronic acid when followed by the N-acetylglucosamine, were observed. Iduronic acid residues, followed by 6- O-sulfate glucosamine (A (Nx,6S)), and the glucuronic acid residues, followed by A (NS) residues, were not modified. A few minor internal chain modifications occur, possibly arising from oxidative breaking of the bond between C2-C3 of glucosamine and uronic acids, suggested by evidence of formation of new -COR groups. Finally, no change was observed in the content of the N-sulfated, 6-O-sulfated glucosamine bearing an extra sulfate on 3-O, which is considered the marker of the active site for antithrombin. With respect to the original heparin, this LMWH is characterized by a lower number of nonsulfated uronic acid residues, and as a consequence, by a lower degree of structural heterogeneity than LMWHs prepared with other procedures.
Similar articles
-
Structural characterization of low molecular weight heparins.Semin Thromb Hemost. 1999;25 Suppl 3:17-25. Semin Thromb Hemost. 1999. PMID: 10549712 Review.
-
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.Anal Bioanal Chem. 2014 Jan;406(1):249-65. doi: 10.1007/s00216-013-7446-4. Epub 2013 Nov 20. Anal Bioanal Chem. 2014. PMID: 24253408 Free PMC article.
-
Susceptibility of enoxaparin reducing end amino sugars to periodate oxidation.Carbohydr Res. 2014 Dec 5;400:33-43. doi: 10.1016/j.carres.2014.08.016. Epub 2014 Sep 10. Carbohydr Res. 2014. PMID: 25457608 Free PMC article.
-
Variability in the carbazole assay for N-desulfonated/N-acylated heparin derivatives.Carbohydr Res. 2007 Dec 10;342(17):2664-9. doi: 10.1016/j.carres.2007.08.004. Epub 2007 Aug 23. Carbohydr Res. 2007. PMID: 17850773
-
Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy.Semin Thromb Hemost. 2007 Jul;33(5):478-87. doi: 10.1055/s-2007-982078. Semin Thromb Hemost. 2007. PMID: 17629844 Review.
Cited by
-
Expanding the Role of Heparin Derivatives in Oncology: From Anticoagulation to Antitumor Activity.Pharmaceuticals (Basel). 2025 Mar 12;18(3):396. doi: 10.3390/ph18030396. Pharmaceuticals (Basel). 2025. PMID: 40143176 Free PMC article. Review.
-
Non-Anticoagulant Activities of Low Molecular Weight Heparins-A Review.Pharmaceuticals (Basel). 2023 Sep 5;16(9):1254. doi: 10.3390/ph16091254. Pharmaceuticals (Basel). 2023. PMID: 37765064 Free PMC article. Review.
-
Photochemical Preparation of a Novel Low Molecular Weight Heparin.Carbohydr Polym. 2012 Feb 1;67(2):1737-1743. doi: 10.1016/j.carbpol.2011.09.087. Carbohydr Polym. 2012. PMID: 22205826 Free PMC article.
-
Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical Approach.Molecules. 2017 Jul 5;22(7):1116. doi: 10.3390/molecules22071116. Molecules. 2017. PMID: 28678201 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous